It refers to the sagging in the face that some people see after losing a large amount of weight on the medication
Diabetes 51:34403449 Nathan DM, Schreiber E, Fogel H, Mojsov S, Habener JF (1992) Insulinotropic action of glucagonlike peptide-I-(737) in diabetic and nondiabetic subjects
Back Holst, JJ (26 April 2019) 'From the Incretin Concept and the discovery of GLP-1 to today's diabetes therapy', Frontiers in Endocrinology , 10
Cholesterol is the end product of the mevalonate pathway, and other intermediates of this pathwayparticularly squalenemay also regulate ferroptosis (54)
I love being able to have help staying healthy and managing my weight
Prescribers may check a baseline triglyceride level, ask carefully about alcohol use and any prior episodes, and make sure you know the warning symptoms before you start